Precision BioSciences (DTIL) Beats Q3 Earnings Estimates by $0.64
Precision BioSciences (NASDAQ:DTIL) reported quarterly earnings results on November 03, 2026 that exceeded analyst expectations.
Read moreReal-time context
Company earnings results and notable reporting developments.
Precision BioSciences (NASDAQ:DTIL) reported quarterly earnings results on November 03, 2026 that exceeded analyst expectations.
Read moreJBT Marel (NYSE:JBTM) reported quarterly earnings results on November 03, 2026 that exceeded analyst expectations.
Read moreFaeth Therapeutics (NASDAQ:FTH) reported quarterly earnings results on November 03, 2026 that fell short of analyst expectations.
Read moreEco Wave Power Global (NASDAQ:WAVE) reported quarterly earnings results on November 03, 2026 that exceeded analyst expectations.
Read moreGiftify (NASDAQ:GIFT) reported quarterly earnings results on November 03, 2026 that fell short of analyst expectations.
Read moreCURLF (NASDAQ:CURLF) is scheduled to report its Q3 earnings results on November 03, 2026 after market close.
Read moreEnergy Transfer LP (NYSE:ET) is scheduled to report its Q3 earnings results on November 03, 2026 after market close.
Read moreFresenius Medical Care AG & Co. KGaA (NYSE:FMS) is scheduled to report its Q3 earnings results on November 03, 2026 after market close.
Read moreImmunityBio, Inc. (NASDAQ:IBRX) is scheduled to report its Q3 earnings results on November 03, 2026 after market close.
Read moreGEF (NASDAQ:GEF) is scheduled to report its Q4 earnings results on November 03, 2026 after market close.
Read moreFatPipe, Inc. Common Stock (NASDAQ:FATN) is scheduled to report its Q2 earnings results on November 03, 2026 after market close.
Read moreWerewolf Therapeutics, Inc. (NASDAQ:HOWL) is scheduled to report its Q3 earnings results on November 03, 2026 after market close.
Read moreVaxcyte, Inc. Common Stock (NASDAQ:PCVX) is scheduled to report its Q3 earnings results on November 03, 2026 after market close.
Read moreIDEAYA Biosciences, Inc. (NASDAQ:IDYA) is scheduled to report its Q3 earnings results on November 03, 2026 after market close.
Read moreSunoco LP (NYSE:SUN) is scheduled to report its Q3 earnings results on November 03, 2026 after market close.
Read moreMarqeta, Inc. (NASDAQ:MQ) is scheduled to report its Q3 earnings results on November 03, 2026 after market close.
Read moreNuvectis Pharma, Inc. (NASDAQ:NVCT) is scheduled to report its Q3 earnings results on November 03, 2026 after market close.
Read moreSpyre Therapeutics, Inc. (NASDAQ:SYRE) is scheduled to report its Q3 earnings results on November 03, 2026 after market close.
Read moreOculis Holding AG (NASDAQ:OCS) is scheduled to report its Q3 earnings results on November 03, 2026 after market close.
Read moreTXO Partners, L.P. (NYSE:TXO) is scheduled to report its Q3 earnings results on November 03, 2026 after market close.
Read more